Biotech startup uses tobacco plants to make vaccines

03/22/2012 | InnovationNewsDaily.com

U.S. biotech startup Inserogen has transformed tobacco plants into biological factories for manufacturing proteins for new vaccines and treatments. Using the SwiftVax tobacco plants, the startup is developing a vaccine for Newcastle disease, and a therapeutic protein for patients with alpha-1 antitrypsin deficiency. "The technology is easy to customize, and can be engineered to produce not only vaccines, but virtually any recombinant protein," Inserogen's Lucas Arzola said.

View Full Article in:

InnovationNewsDaily.com

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
CarePoint Health Plan
Jersey City, NJ
Regional Director, Southeastern Region - State Affairs
America's Heatlh Insurance Plans (AHIP)
Washington, DC
Pharmacy Care Manager
National Association of Chain Drug Stores
Arlington, VA
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Director, Compliance - Health Plan Privacy & Security
Kaiser Permanente
Oakland, CA